AWA
EMN icon

Arete Wealth Advisors’s Eastman Chemical EMN Stock Holding History

Arete Wealth Advisors’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,868
Closed -$341K – 745
2025
Q1 		$341K Sell
3,868
-210
-5% -$19.8K 0.03% 492
2024
Q4 		$371K Buy
4,078
+483
+13% +$49.5K 0.03% 502
2024
Q3 		$402K Buy
3,595
+205
+6% +$20.5K 0.03% 430
2024
Q2 		$331K Buy
+3,390
New +$336K 0.03% 512
2024
Q1 		– Sell
-3,782
Closed -$340K – 469
2023
Q4 		$340K Buy
3,782
+35
+0.9% +$2.79K 0.03% 518
2023
Q3 		$287K Sell
3,747
-705
-16% -$58.5K 0.05% 354
2023
Q2 		$373K Buy
4,452
+754
+20% +$61.3K 0.03% 431
2023
Q1 		$312K Buy
3,698
+294
+9% +$25.3K 0.03% 466
2022
Q4 		$277K Buy
+3,404
New +$274K 0.02% 475

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Arete Wealth Advisors's EMN Position: Q2 2025 in Review

Arete Wealth Advisors sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 3,868 shares — an estimated $341K sold.

Arete Wealth Advisors first reported a position in EMN in Q4 2022 and held it in 9 quarters. The position peaked at $402K in Q3 2024. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2025.

  • Arete Wealth Advisors reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
  • Arete Wealth Advisors sold 3,868 Eastman Chemical shares in Q2 2025, an estimated $341K.
  • Arete Wealth Advisors first reported a position in Eastman Chemical in Q4 2022 and held it in 9 quarters.
  • Arete Wealth Advisors's Eastman Chemical position peaked at $402K in Q3 2024.
  • 751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.

Based on Arete Wealth Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.